New recommendations suggest reforming the federal 340b drug discount program. Originally designed to help providers serve the poor or underinsured, misuse has raised concerns for greater transparency in prices and how hospitals are using 340b savings.
New recommendations suggest reforming the federal 340b drug discount program. Originally designed to help providers serve the poor or underinsured, misuse has raised concerns for greater transparency in prices and how hospitals are using 340b savings. Modern Healthcare reports:
Safety net hospitals issued recommendations Tuesday for reforming the federal 340b drug discount program, which was designed to help clinics and hospitals serving the poor and uninsured but has become controversial because of alleged misuse by some hospitals.
The recommendations included increased transparency of 340b prices and how hospitals use 340b savings, audits of drug manufacturers and more scrutiny of contract pharmacies that participate in the program. They were released by the Safety Net Hospitals for Pharmaceutical Access, a trade group that represents more than half of the participating 340b hospitals.
Roughly one third of the nation's hospitals participate in the 340b program, and that growth has fueled a debate about reforming the decades-old program.
Read the full story here: http://bit.ly/16qozWX
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More